BioSpace News Archive

Press Releases

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen

July 23, 2024
·
6 min read
Press Releases

SpringWorks Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

July 23, 2024
·
1 min read
Press Releases

SCYNEXIS to Receive $10 Million Milestone Payment from GSK Triggered by Delivery of Completed FURI, CARES and NATURE Clinical Study Reports

July 23, 2024
·
3 min read
Press Releases

Frontier Medicines Announces Milestone Payment in AbbVie Partnership, Following Advancement of Lead Candidates Targeting a Historically Undruggable Transcription Factor

July 23, 2024
·
2 min read
Press Releases

Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease

July 23, 2024
·
10 min read
Press Releases

David Rubenstein Joins Moderna’s Board of Directors

July 23, 2024
·
6 min read
Press Releases

AbbVie’s EPKINLY™ Receives First-Ever Time-Limited Reimbursement Recommendation by Canada’s Drug Agency

July 23, 2024
·
7 min read
Press Releases

Allucent Names Paula Brown Stafford as CEO

July 23, 2024
·
4 min read
Press Releases

Voydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults with the rare disease PNH who have residual hemolytic anemia due to extravascular hemolysis

July 23, 2024
·
9 min read
Press Releases

FDA Accepts Mesoblast’s Biologics License Application (BLA) for Ryoncil® in Children With Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)

July 23, 2024
·
10 min read